Literature DB >> 18815077

Arginine and methylated arginines in human plasma and urine measured by tandem mass spectrometry without the need for chromatography or sample derivatisation.

Gary Weaving1, Bernard F Rocks, Michael P Bailey, Michael A Titheradge.   

Abstract

A method for the simultaneous analysis of asymmetric dimethylarginine, symmetric dimethylarginine, monomethylarginine and arginine in human plasma and urine, with short analysis time and isotopic internal standardisation for each analyte is described. The method requires neither sample derivatisation nor the need for chromatographic separation of analytes. The method described shows good precision and accuracy and is suited for both research purposes and implementation in the busy, routine clinical laboratory. In addition the synthesis and utilisation of isotopically labelled symmetric dimethylarginine and monomethylarginine is described for the first time, avoiding the use of surrogates such as homoarginine for internal standardisation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815077     DOI: 10.1016/j.jchromb.2008.08.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Heat-assisted extraction for the determination of methylarginines in serum by CE.

Authors:  Thomas H Linz; Susan M Lunte
Journal:  Electrophoresis       Date:  2013-06       Impact factor: 3.535

Review 2.  Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic Diseases.

Authors:  Mustafa E Sitar
Journal:  Biomark Insights       Date:  2016-12-07

3.  Developing a robust, fast and reliable measurement method for the analysis of methylarginine derivatives and related metabolites.

Authors:  Duygu Eryavuz Onmaz; Sedat Abusoglu; Havva Yaglioglu; Gulsum Abusoglu; Ali Unlu
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2021-03-06

Review 4.  Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Authors:  Luis Aldámiz-Echevarría; Fernando Andrade
Journal:  Int J Mol Sci       Date:  2012-09-10       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.